共 31 条
Development of the Korean version of Alzheimer's disease assessment scale (ADAS-K)
被引:34
作者:
Youn, JC
Lee, DY
Kim, KW
Lee, JH
Jhoo, JH
Lee, KU
Ha, J
Woo, JI
机构:
[1] Seoul Natl Univ, Coll Med, Dept Neuropsychiat, Chongno Gu, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[3] Seoul Natl Univ, Neurosci Res Inst, Med Res Ctr, Seoul 151, South Korea
[4] Seoul Natl Univ Hosp, Clin Res Inst, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
[6] Kyunggi Provincial Hosp Elderly, Dept Neuropsychiat, Kyunggido, South Korea
[7] Kangwon Natl Univ, Coll Med, Dept Neuropsychiat, Kangwon Do, South Korea
[8] Metro Hosp, Dept Neuropsychiat, Kyunggido, South Korea
[9] Korean Assoc Dementia, Seoul, South Korea
关键词:
ADAS-K;
ADAS-K-cog;
ADAS-K-noncog;
reliability;
validity;
D O I:
10.1002/gps.699
中图分类号:
R592 [老年病学];
C [社会科学总论];
学科分类号:
03 ;
0303 ;
100203 ;
摘要:
Objective The purpose of this study was the development of the Korean Version of Alzheimer's Disease Assessment Scale (ADAS-K). Method ADAS-K was administrated to 84 AD patients as well as 105 non-demented control subjects. Three aspects of reliability were tested. To evaluate the validity of ADAS-K, discriminant validity and concurrent validity were tested. To evaluate the sensitivity of ADAS-K to disease severity, all subjects, AD patients and control subjects, were grouped by CDR scale and their mean scores on ADAS-K were compared. Result ADAS-K demonstrated high levels of reliability. Mean ADAS-K scores for AD patients were significantly different from the control group (p < 0.01). Furthermore, ADAS-K exhibited significant correlations with other tests and scales (range 0.45-0.85, p < 0.01). In ROC curve analysis, ADAS-K displayed high diagnostic efficacy and the optimal cut-off point was selected between 18/19. ADAS-K was able to discriminate. the degree of AD severity according to CDR classification. Our results suggested that ADAS-K-cog was sensitive to very mild AD. Conclusion We demonstrated that ADAS-K is a reliable and valid instrument not only for AD diagnosis but also for evaluation of its severity. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:797 / 803
页数:7
相关论文